Starting from the aforementioned observations, our study has the intent to investigate whether the anti-tumoral effects brought by β3-AR antagonism in NB tumor, could in part rely on the reinvigoration of the anti-tumor immunity, and whether this could involve the modulation of immune checkpoints signaling pathways. This evidence concerns the gene ADRB3 and neuroblastoma.